purpose of reducing the deficit in the separate financial statements of the Company. 5 November 2018: U City’s ordinary and preferred shares start trading at new par value. The reverse stock split which
Profit (Loss) (16.93) (2.20) 14.73 669.55 Earnings per share (Baht per share) (0.0032) (0.0005) 0.0027 540.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 16.93
Par Value Baht 1 NTD 10 NTD 10 NTD 10 Book Value Per Share USD 0.113 USD 1.64 USD 1.56 USD 1.29 Criteria Transaction Size (%) 1. Net Tangible Assets Value 6.20% 2. Net Profit (12-month period) 32.52% 3
% 63 (119) -290% Elimination (52) (3) (7) (99) (10) Profit attributable to owners of the Company 993 1,146 1,007 1% -12% 3,076 2,153 -30% Basic earnings per share (Baht) 0.72 0.83 0.73 2.23 1.56 Note: 1
“Company”) submitted its separate financial statement and its consolidated financial statement for the first quarter of 2018 ended on 31 March 2018 which were reviewed by the auditor. The Company hereby
“Company”) submitted its separate financial statement and its consolidated financial statement for the second quarter of 2019 ended on 30 June 2019 which were reviewed by the auditor. The Company hereby
interim dividend payment of 0.35 Baht per share (THB 1,051.31 million) from the Company’s operating results based on separate financial statements for the period January - June 2019, which showed the net
reduction for the purpose of reducing the deficit in the separate financial statements of the Company. 5 November 2018: U City’s ordinary and preferred shares start trading at new par value. The reverse stock
Financial performances Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% Q1/2019 Q1/2018 Q1/2018 Q1/2017 Revenues from sales and services of medical equipment 460,711 366,698 26% 382,283 320,648
Consolidated ∆% Separate ∆% Q1/2018 Q1/2017 Q1/2018 Q1/2017 Revenues from sales and services 529,514 669,009 -21% 320,648 445,078 -28% Interest income 121 363 -67% 121 8,930 -99% Gain on disposal of assets